^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    HCCBloodTest

    Company:
    Epigenomics
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The HCCBloodTest is an in-vitro polymerase chain reaction (PCR) assay for the qualitative detection of Septin 9 gene methylation (SEPT9) in DNA isolated from 3.5 mL of patient plasma. The SEPT9 gene is a key regulator of cell division and tumor suppressor and the hypermethylation of the assessed marker site is associated with liver carcinogenesis.
    Cancer:
    Hepatocellular Cancer
    Gene:
    SEPTIN9 (Septin 9)
    Method:
    PCR
    Confirmatory trial(s)
    NCT03804593
    |
    BMC Gastroenterol